Spectrum of disease in familial focal and segmental glomerulosclerosis

被引:50
作者
Conlon, PJ
Lynn, K
Winn, MP
Quarles, LD
Bembe, ML
Pericak-Vance, M
Speer, M
Howell, DN
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
[4] Durham Vet Hosp, Durham, NC USA
[5] Christchurch Hosp, Dept Med, Christchurch, New Zealand
关键词
glomerulonephritis; renal disease; genetics; FSGS; inherited FSGS;
D O I
10.1046/j.1523-1755.1999.00727.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Focal segmental glomerulosclerosis (FSGS) is the underlying pathologic entity in 5% of adults and 20% of children with end-stage renal disease (ESRD). FSGS is generally considered to be sporadic in origin. Methods. Recently, we identified 60 families involving 190 individuals with familial FSGS, providing evidence for a subset of families in which a genetic form is segregating. Each family had at least one member with renal biopsy-confirmed FSGS and at least one other member with either renal biopsy-confirmed FSGS or ESRD. Results. Twenty-six families had individuals affected in more than one generation [multigeneration (MG)], and the remaining 34 families had only a single generation (SG) affected. There was equal representation of males and females among affected individuals. Ten percent of MG families were African American. and 52% of SG families were African American. The mean age of presentation was significantly higher in the MG families (32.5 +/- 14.6 years) compared with the SG families (20.1 +/- 12.1 years, P = 0.0001). SG cases had higher levels of proteinuria at presentation (7.0 +/- 5.6 g/24 hr, compared with 3.8 +/- 3.4 g/24 hr, for the MG families, P = 0.002). On renal biopsy, tubulointerstitial damage was more severe in patients in the SG families than in the MG families; however, the level of glomerular damage did not differ between these groups. Fifty percent of the patients had progressed to ESRD by the age of 30 years. Variables measured at presentation that were independently associated with poor renal survival were decreased age, increased serum creatinine, and increased urinary protein excretion. Forty-one patients underwent successful renal transplantation, with a 10-year graft survival rate of 62%. One patient developed clinical and biopsy evidence of recurrence of FSGS in the allograft. Conclusion. These data confirm the existence of a non-Alport's form of hereditary glomerulonephritis, which has a morphological pattern of FSGS.
引用
收藏
页码:1863 / 1871
页数:9
相关论文
共 50 条
  • [21] Mechanisms of Scarring in Focal Segmental Glomerulosclerosis
    Zhong, Jianyong
    Whitman, Jacob B.
    Yang, Hai-Chun
    Fogo, Agnes B.
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2019, 67 (09) : 623 - 632
  • [22] Educational feature on focal segmental glomerulosclerosis (FSGS): an introduction
    Trachtman, Howard
    [J]. PEDIATRIC NEPHROLOGY, 2007, 22 (01) : 26 - 27
  • [23] Educational feature on focal segmental glomerulosclerosis (FSGS): an introduction
    Howard Trachtman
    [J]. Pediatric Nephrology, 2007, 22 : 26 - 27
  • [24] Infection-Related Focal Segmental Glomerulosclerosis in Children
    Dettmar, Anne Katrin
    Oh, Jun
    [J]. BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [25] Recurrent focal segmental glomerulosclerosis after kidney transplantation
    Trachtman, Rebecca
    Sran, Simranjeet S.
    Trachtman, Howard
    [J]. PEDIATRIC NEPHROLOGY, 2015, 30 (10) : 1793 - 1802
  • [26] Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis
    Zee, Jarcy
    Liu, Qian
    Smith, Abigail R.
    Hodgin, Jeffrey B.
    Rosenberg, Avi
    Gillespie, Brenda W.
    Holzman, Lawrence B.
    Barisoni, Laura
    Mariani, Laura H.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (07): : 1411 - 1426
  • [27] Mutation in XPO5 causes adult-onset autosomal dominant familial focal segmental glomerulosclerosis
    Hussain, Hafiz Muhammad Jafar
    Cai, Yikai
    Weng, Qinjie
    Tong, Jun
    Aftab, Ayesha
    Jin, Yuanmeng
    Liu, Jian
    Yu, Shuwen
    Fang, Zhengying
    Du, Wen
    Pan, Xiaoxia
    Ren, Hong
    Xie, Jingyuan
    [J]. HUMAN GENOMICS, 2022, 16 (01)
  • [28] Focal segmental glomerulosclerosis as a complication of graft-versus-host disease
    Fofi, Claudia
    Barberi, Simona
    Stoppacciaro, Antonella
    Punzo, Giorgio
    Mene, Paolo
    [J]. NATURE REVIEWS NEPHROLOGY, 2009, 5 (04) : 236 - 240
  • [29] Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis
    Fernandez-Juarez, Gema
    Villacorta, Javier
    Ruiz-Roso, Gloria
    Panizo, Nayara
    Martinez-Marin, Isabel
    Marco, Helena
    Arrizabalaga, Pilar
    Diaz, Montserrat
    Perez-Gomez, Vanessa
    Vaca, Marco
    Rodriguez, Eva
    Cobelo, Carmen
    Fernandez, Loreto
    Avila, Ana
    Praga, Manuel
    Quereda, Carlos
    Ortiz, Alberto
    [J]. CLINICAL KIDNEY JOURNAL, 2016, 9 (03): : 381 - 386
  • [30] Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis
    Siligato, Rossella
    Cernaro, Valeria
    Nardi, Chiara
    De Gregorio, Francesca
    Gembillo, Guido
    Costantino, Giuseppe
    Conti, Giovanni
    Buemi, Michele
    Santoro, Domenico
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (11) : 839 - 879